O xygen and nutrient delivery in developing embryos depends on the formation of vascular networks, and many pathologies, including solid tumor growth, also involve the development and remodeling of blood vessels. 1 Growth factors released from nutrient-deprived tissues initiate angiogenic sprouting from preexisting vessels. Endothelial cells emerge from parent vessels and begin migrating outward using local guidance cues to ensure proper extension. 2 As the sprout lengthens, extrinsic patterning cues provided by other cell types and the extracellular matrix guide the sprout toward other vessels or sprouts. 3, 4 A connection forms between the nascent sprout and its target, and this newly formed branch acquires a patent lumen for blood flow. 5 A range of molecular mechanisms, including the vascular endothelial growth factor (VEGF) and Notch pathways, regulate these cellular processes for vascular network expansion.
VEGF-A induces and directs endothelial cell sprouting. Binding of VEGF-A to the tyrosine kinase receptor Flk-1 (VEGF receptor-2) initiates signaling in endothelial cells to promote migration, proliferation, and survival. 6 Flt-1 (VEGF receptor-1) binds VEGF-A with 10-fold higher affinity than Flk-1 but acts primarily as a ligand sink, limiting the amount of VEGF-A that can access the Flk-1 receptors on the endothelial cell surface. 7 Both membrane-bound Flt-1 and soluble Flt-1 modulate endothelial cell proliferation, 8 
but soluble
Flt-1 uniquely regulates vessel branching by contributing to a local sprout guidance mechanism. 2 Expression of both VEGF receptors is regulated during sprouting angiogenesis as part of a dynamic competition among endothelial cells to lead the extending sprout, 9 and the Notch pathway is important in the competition for tip cell position.
The Notch pathway facilitates cell-cell communication in many contexts, and it is important for lateral inhibition. 10 As one cell acquires a particular role or fate, the Notch pathway is used to restrict neighboring cells from acquiring the same fate or phenotype, as seen in Drosophila trachea development, 11 and epidermal differentiation. 12 Endothelial cells express the Notch1 and Notch4 receptors, as well as the ligands deltalike 1 (Dll1), Dll4, Jagged1, and Jagged2. 13 Ligand binding of Notch receptors leads to a series of enzymatic cleavages that result in release of the intracellular domain. The Notch intracellular domain translocates into the nucleus and forms a complex that activates the transcription of target genes, such as Hes and Hey. Notch coordinates vessel sprouting such that suppression of Notch signaling yields increased vessel sprouting. 9, 14 The Notch pathway also negatively modulates endothelial cell division, and reduced Notch signaling promotes endothelial cell proliferation. 15 Crosstalk between the VEGF and Notch pathways is important for orchestrating endothelial cell behaviors during angiogenesis. 16, 17 In response to VEGF stimulation, some endothelial cells initiate new sprouts and emerge as tip cells, whereas other cells follow as stalk cells and contribute to vessel expansion through proliferation. 18 To accomplish this coordination, VEGF signals through Flk-1 to increase Dll4 expression on emerging tip cells. Tip cell Dll4 ligands engage Notch receptors on adjacent stalk cells to reduce their sensitivity to VEGF through increased expression of Flt-1 19, 20 and reduced expression of Flk-1 and Flt-4. [21] [22] [23] [24] Here, we directly test the hypothesis that Flt-1 is critical to VEGF-Notch crosstalk in developing blood vessels. We show that Flt-1 is upstream of Notch signaling through regulation of VEGF signaling and thus mediates an important feedback loop in VEGF-Notch pathway crosstalk during blood vessel formation.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Notch Inhibition Rescues Branching and Proliferation Defects in flt-1 −/− Vessels
Loss of Flt-1 leads to vessel overgrowth and branching dysmorphogenesis through elevated VEGF signaling. 7, 8, 25 Because Notch signaling is activated by VEGF signaling, 17 we hypothesized that elevated VEGF signaling as a result of genetic loss of flt-1 increases Notch signaling and contributes to vessel branching defects. To test this hypothesis, we used differentiation of mouse embryonic stem (ES) cells in vitro to form primitive lumenized vessel networks in the context of other embryonic cell types. 26 Although these vessels lack blood flow, their development in vitro mimics in vivo development of primitive vessel networks. 27 To further investigate Flt-1 interactions with Notch, we disrupted Notch signaling with Dll4-Fc, a competitive inhibitor of Notch-Dll4 interactions. 28 Similar to Notch inhibition with DAPT, WT ES cell-derived vessel branching, area, and endothelial cell mitotic index were unaffected by Dll4-Fc treatment ( Figure 2A -2C and 2G-2I). However, the reduced vessel branching and elevated endothelial cell mitotic index of Figure 2D -2F and 2I). Taken together, these results indicate that although reduced Notch signaling increased WT tip cells, this did not affect WT vessel branching; in contrast, vessels lacking flt-1 function were phenotypically rescued by Notch blockade.
Because WT ES cell-derived vessels were unexpectedly phenotypically unaffected by Notch blockade, we asked whether this was a model-specific effect or evidence that Notch effects are also context dependent in vivo. To test this idea, we analyzed the developing vessels in the zebrafish embryo, an established model of blood vessel formation that occurs in the context of blood flow. 29 Notch manipulations in zebrafish are reported to affect vessel formation in certain scenarios, 30, 31 but not all situations of vessel growth. 32 Furthermore, the caudal vein plexus does not exhibit detectable Notch activation via Notch reporter readout (Wiley et al, 33 in revision). Therefore, we subjected zebrafish embryos to Notch inhibition via DAPT treatment and analyzed them for vascular defects. We found perturbed intersegmental vessel (ISV) development in Notch-inhibited embryos ( Figure 3A-3C ), similar to previous reports. 30, 31 However, in these same embryos, the caudal vein plexuses were unaffected, as determined by the presence of multiple lumenized vessels conducting blood flow. ( Figure 3A-3C ). These observations demonstrate that effects of Notch inhibition on blood vessel formation in vivo are also context dependent.
VEGF-A-Disrupted Vessel Morphology Is Affected by Notch Blockade
Because loss of flt-1 elevates VEGF-A-mediated signaling, 8 we reasoned that the differences in response to Notch blockade between WT and flt-1 −/− ES cell-derived vessels might result from the amount of VEGF signaling experienced by the vessels.
Thus, we hypothesized that Notch inhibition would elicit changes in WT vessels exposed to ectopic VEGF-A. To test this idea, we inhibited Notch signaling in WT and flt-1 −/− vessels with and without addition of exogenous VEGF-A. The added VEGF-A caused a significant decrease in WT vessel branching and an increase in endothelial proliferation and vessel area, suggesting that added VEGF-A recapitulates, although not fully, the loss of flt-1 ( Figure 4A -4C and 4G-4I). Notch inhibition of VEGF-A-treated WT vessels partially normalized these changes ( Figure 4A -4C and 4G-4I). VEGF-A treatment of flt-1 −/− ES cell-derived vessels had no effect on vessel branching, area, or endothelial mitotic index, consistent with the idea that loss of Flt-1 elevates VEGF signaling independent of additional ligand ( Figure 4D-4I ). Exposure to ectopic VEGF-A and Notch blockade rescued flt-1 −/− vessel branching dysmorphogenesis and endothelial mitotic index without vessel area rescue, similar to Notch blockade alone ( Figure 4D-4I ). These results indicate that WT vessels are not intrinsically defective in Notch-mediated responses, but rather that Notch responsiveness depends on the level of VEGF signaling.
We next manipulated VEGF and Notch signaling in zebrafish embryos to further explore the influence of VEGF signaling levels on the Notch responsiveness of developing blood vessels. Zebrafish ISVs are more sensitive to VEGF manipulations than the caudal vein plexus. 33 For this reason, we focused on ISV defects in Notch-inhibited embryos with and without the overexpression of Vegfaa via heat-shock induction of the Tg(hsp70l:vegfaa) transgene. Increased Vegfaa induced significant morphological perturbations in the ISVs of developing zebrafish (Figure 5A , 5C, and 5E). Notch blockade in embryos overexpressing Vegfaa led to an additional and significant increase in ISV defects ( Figure 5B and 5D-5F). Although zebrafish vessels exposed to Notch blockade, in conjunction with increased VEGF signaling, exhibited a distinct phenotypic outcome from ES cell-derived vessels, the interaction between the VEGF and Notch pathways was consistent between the 2 models as seen by the increase in defective zebrafish ISVs. Taken together, these observations indicate that endothelial cells vary in their responsiveness to Notch, depending on VEGF signaling levels.
Elevated Notch Target Gene Expression in flt-1 −/− Vessels Is Rescued by Notch Blockade
To determine whether Notch pathway transcriptional targets are elevated in flt-1 −/− mutant vessels, we dissociated WT and flt-1 −/− ES cell cultures and used magnetic bead-assisted cell sorting to enrich for endothelial cells. Real-time quantitative polymerase chain reaction was used to assess RNA levels of the Notch targets hey1, dll4, and nrarp. As expected, Flt-1 RNA levels were reduced in enriched endothelial cell preparations from flt-1 −/− vessels, whereas all 3 Notch targets were increased ≥5-fold ( Figure 6A ). Interestingly, Notch target gene RNA levels in WT-enriched endothelial cell preparations showed no significant changes with Notch blockade (Figure 6Aii-6Aiv) . In contrast, the elevated expression of Notch targets in flt-1 −/− mutant preparations was rescued back down toward WT levels with Notch blockade (Figure 6Aii-6Aiv) .
We next evaluated protein levels of Notch pathway components in WT and flt-1 −/− endothelial cell-enriched preparations exposed to Notch blockade. Protein levels of the transcription factor Hey1 and the Notch1 ligand Dll4, which are also Notch targets, were also highly elevated in the flt-1 −/− EC-enriched preparations ( Figure 6B ). These elevated levels of Notch targets were partially rescued with Notch blockade. However, Notch targets were unchanged in WT EC-enriched preparations exposed to Notch blockade ( Figure 6B ). The lack of change in Notch target gene expression in the WT scenario supports the finding that Notch blockade does not affect the overall morphology of WT ES cell-derived vessels, whereas the elevation with loss of flt-1 and partial rescue with Notch blockade suggest that Notch is a required effector downstream of elevated VEGF signaling.
Discussion
The rescue of flt-1 −/− ES cell-derived vessel branching dysmorphogenesis by Notch blockade demonstrates that Flt-1 regulation of VEGF signaling upstream of the Notch pathway is critical for normal vascular development. In addition, VEGF overexpression in zebrafish impaired the ability of Flt-1 to modulate VEGF activity and induced ISV defects that were further affected by Notch suppression. Previous studies showed that Flt-1 expression was upregulated downstream of Notch signaling, but did not critically test flt-1 function in the crosstalk. 9, 20, 22, 34, 35 Our data support an additional requirement for flt-1 upstream of Notch via modulation of VEGF signaling. Thus, Flt-1 mediates a critical component of the feedback loop that governs coordination of endothelial cell behavior during vascular development ( Figure 6C ).
We propose that Flt-1 mediates crosstalk between the VEGF and Notch pathways by keeping VEGF signaling at appropriate levels to effectively use Notch for lateral inhibition (Figure 6Cii ). Furthermore, Flt-1 completes the VEGF-Notch feedback loop by further reinforcing the differential responsiveness of endothelial cells to the oncoming VEGF. Loss of Flt-1 modulation of VEGF signaling results in excessively high Notch signaling, undermining the VEGF-Notch feedback loop and disrupting coordination of endothelial cell phenotypes (Figure 6Ciii ). Thus, flt-1 −/− endothelial cells are predicted to experience excessive lateral inhibition via Notch signaling. Consistent with this model, we found that the reduced branching and elevated endothelial proliferation in flt-1 −/− blood vessel networks 25, 36 were rescued by lowering elevated levels of Notch signaling through Notch blockade. Notch blockade in zebrafish ISVs exposed to ectopic VEGF elicited additional changes in vessel morphology, suggesting that VEGF-mediated effects on vessel formation are influenced by Notch manipulation. RNA and protein levels of Notch targets in ES cell-derived endothelial cells are Excessive flt-1 −/− endothelial cell proliferation is reduced with Notch inhibition, suggesting a unique relationship between upstream Flt-1 regulation of VEGF signaling and the downstream Notch pathway in modulating endothelial proliferation. Increased Notch signaling causes endothelial cells to adopt a stalk cell phenotype 14 but is also known to suppress endothelial cell proliferation. 17, 19, [38] [39] [40] However, stalk cells are presumed to undergo division more frequently than tip cells for sprout elongation, 18 which is seemingly incongruent with stalk cells experiencing elevated Notch signaling. 14 Interestingly, flt-1 mutant endothelial cells overproliferate, despite having elevated levels of Notch signaling, and both elevated Notch target levels and elevated endothelial cell division were rescued by Notch blockade. In one model consistent with these observations, flt-1 −/− endothelial cells have elevated lateral inhibition (Figure 6Ciii ), and Notch blockade releases some endothelial cells from this lateral inhibition, allowing them to contribute more to branching and less to vessel expansion via proliferation. Nevertheless, further investigation will be required to elucidate how Flt-1 integrates VEGF and Notch signals to regulate endothelial cell division.
WT ES cell-derived vessels and zebrafish embryo caudal vein plexus exposed to Notch blockade showed no obvious changes in overall vessel morphology or endothelial cell proliferation, despite an increase in tip cell numbers, and Notch blockade did not affect Notch target gene expression levels in WT endothelial cells. In contrast, Notch blockade in the postnatal retina, tumors, and wound healing models increases vessel density and branching, although these increases do not necessarily result in more lumenized conduits. 14, 22, [41] [42] [43] Thus, an increase in tip cells may not inherently result in more patent vessel branches, as seen in the current study. Furthermore, not all Notch perturbations affect vessel branching, as previous observations of embryonic and yolk sac vessels in Notchmanipulated mice revealed defects in network remodeling and arteriovenous specification rather than plexus formation. [44] [45] [46] These data and our results suggest that non-Notch pathways may act in parallel or in place of Notch to regulate vessel branching in certain situations. We hypothesized that the level of VEGF signaling might determine the involvement of Notch signaling in endothelial cells and thus their response to Notch blockade. Indeed, we found that adding VEGF ligand to ES cell-derived vessels or developing zebrafish ISVs affected vessel formation, and Notch blockade had additional effects on these vessels. These results are consistent with previous studies showing that endothelial cells respond to Notch inhibition more strongly with added VEGF. 32, 47, 48 Thus, Notch-based therapies will need to be developed with consideration of the treatment context.
Pathological conditions, such as cancer and diabetes mellitus, have as hallmarks misregulated angiogenesis associated with aberrant VEGF signaling. Antiangiogenic therapies, particularly those targeting the VEGF pathway, have had limited success because of acquired resistance and suboptimal efficacy. 49 Notch perturbations in mouse tumor and hind-limb ischemia models increase the formation of poorly perfused vessels. [41] [42] [43] This undermines recovery after ischemia, 41 but for solid tumors it reduces tumor burden, 42, 43 supporting the potential for Notch-based cancer therapies. Thus, understanding the systemic effects of disrupted Notch signaling 50 and how Notch intersects with other pathways will be essential for development of effective treatments. In the present study, we found that Flt-1 is important in VEGF-Notch signaling crosstalk and that loss of flt-1 disrupts VEGF signaling, which in turn perturbs the Notch pathway and contributes to flt-1 −/− vessel dysmorphogenesis. Dll4 signal intensities were normalized to those for corresponding GAPDH control bands, and untreated WT levels were set to 1 for comparison (Bi). Hey1 levels were also compared across treatment groups and cell types using actin control bands, just as described for Dll4 and GAPDH (Bii). Model of Flt-1-mediated crosstalk between the vascular endothelial growth factor (VEGF) and Notch pathways (C). The model illustrates how Flt-1 (blue), and soluble Flt-1 (sFlt-1) in particular (iia-iic), modulates the concentration of available VEGF (green, i-iii) that induces Dll4 expression in endothelial cells (red and pink cells, iia-iic). Notch signaling between adjacent cells (dotted lines in iic) then reinforces competition dynamics for sprouting (iic), which completes the Flt-1-mediated feedback loop between VEGF and Notch signaling pathways (iic). In the absence of Flt-1 activity (iiia-iiic), VEGF induces widespread activation of Dll4 (red cells, iiia-iiic), and thus Notch signaling is elevated, and normal competition dynamics among endothelial cells are disrupted (dotted lines in iiic). In addition, without Flt-1-mediated feedback, VEGF signaling is unchecked (iiic), exacerbating the excessive Notch signaling and further undermining normal sprouting and proliferation.
